Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
or

Sonnet Biotherapeutics Holdings Inc (SONN)

Sonnet Biotherapeutics Holdings Inc (SONN)
1.3000 x 2 1.4200 x 9
Post-market by (Cboe BZX)
1.4200 +0.1400 (+10.94%) 04/23/25 [NASDAQ]
1.3000 x 2 1.4200 x 9
Post-market 1.4200 unch (unch) 15:59 ET
Quote Overview for Wed, Apr 23rd, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
1.2800
Day High
1.4300
Open 1.2800
Previous Close 1.2800 1.2800
Volume 59,300 59,300
Avg Vol 45,245 45,245
Stochastic %K 39.17% 39.17%
Weighted Alpha -82.54 -82.54
5-Day Change +0.1400 (+10.94%) +0.1400 (+10.94%)
52-Week Range 1.1000 - 16.0000 1.1000 - 16.0000
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,939
  • Shares Outstanding, K 3,066
  • Annual Sales, $ 20 K
  • Annual Income, $ -7,440 K
  • EBIT $ -13 M
  • EBITDA $ -13 M
  • 60-Month Beta 0.58
  • Price/Sales 209.76
  • Price/Cash Flow N/A
  • Price/Book 0.98

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year 0.56
  • Growth Rate Est. (year over year) +178,292.86%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.1000 +29.09%
on 04/07/25
Period Open: 1.3800
1.7000 -16.47%
on 04/04/25
+0.0400 (+2.90%)
since 03/21/25
3-Month
1.1000 +29.09%
on 04/07/25
Period Open: 1.7100
1.9300 -26.42%
on 01/27/25
-0.2900 (-16.96%)
since 01/23/25
52-Week
1.1000 +29.09%
on 04/07/25
Period Open: 14.2400
16.0000 -91.13%
on 06/10/24
-12.8200 (-90.03%)
since 04/23/24

Most Recent Stories

More News
Sonnet Releases Virtual Investor "What This Means" Segment

SONN : 1.4200 (+10.51%)
Sonnet’s SON-1010 Demonstrates a Strong Safety Profile in Combination with Atezolizumab for Treatment of Platinum-Resistant Ovarian Cancer, Including a Partial Response at the Highest Dose

SONN : 1.4200 (+10.51%)
Sonnet Announces Release of Corporate Update Video

SONN : 1.4200 (+10.51%)
Sonnet Announces the Passing of Founder and CEO Pankaj Mohan, Ph.D.

SONN : 1.4200 (+10.51%)
Sonnet BioTherapeutics Successfully Completes First Safety Review of SON-1010 in Combination with Trabectedin in Certain Sarcomas

SONN : 1.4200 (+10.51%)
Sonnet BioTherapeutics Receives Notice of Allowance for U.S. Patent Covering Composition of Matter of Specific Amino Acid Substitutions of its IL-18 Binding Protein Resistant Variant Protein

SONN : 1.4200 (+10.51%)
Sonnet BioTherapeutics Holdings, Inc. Participates in the Virtual Investor “Top 5 for ‘25” On-Demand Conference

SONN : 1.4200 (+10.51%)
Virtual Investor Releases Next Wave of "Top 5 for '25" On-Demand Videos

- Access video webcasts from all participating companies here

AIM : 0.0949 (-19.37%)
SONN : 1.4200 (+10.51%)
MBRX : 1.0300 (-1.90%)
Sonnet BioTherapeutics Presents Compilation of Data Highlighting the Potential of SON-1010 as a Monotherapy or a Combination Therapy to Improve the Treatment of Solid Tumors

SONN : 1.4200 (+10.51%)
Sonnet BioTherapeutics Announces That Its Proprietary Antibody Drug Conjugate (ADC) Platform is Available for Drug Discovery Partnerships with Potential for Producing Multiple Pipeline Drug Candidates

SONN : 1.4200 (+10.51%)

Business Summary

Sonnet BioTherapeutics Holdings Inc. is an oncology-focused biotechnology company with a proprietary platform for biologic drugs of single or bispecific action. Sonnet BioTherapeutics Holdings Inc., formerly known as Chanticleer Holdings Inc., is based in PRINCETON, N.J.

See More

Key Turning Points

3rd Resistance Point 1.6233
2nd Resistance Point 1.5267
1st Resistance Point 1.4733
Last Price 1.4200
1st Support Level 1.3233
2nd Support Level 1.2267
3rd Support Level 1.1733

See More

52-Week High 16.0000
Fibonacci 61.8% 10.3082
Fibonacci 50% 8.5500
Fibonacci 38.2% 6.7918
Last Price 1.4200
52-Week Low 1.1000

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective